Ali J. Satvat - 12 Jun 2025 Form 4 Insider Report for Coherus Oncology, Inc. (CHRS)

Role: Director
Signature: /s/ Bryan McMichael, as Attorney in Fact for Ali J. Satvat
Issuer symbol: CHRS
Transactions as of: 12 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 13 Jun 2025, 18:46:21 UTC
Previous filing: 31 Dec 2024
Next filing: 24 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Satvat Ali J.	Director	C/O COHERUS ONCOLOGY, INC., 333 TWIN DOLPHIN DRIVE, SUITE 600, REDWOOD CITY	/s/ Bryan McMichael, as Attorney in Fact for Ali J. Satvat	13 Jun 2025	0001621788

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CHRS	Stock Option (Right to Buy)	Award	$0	+112,000		$0.000000	112,000	12 Jun 2025	Common Stock	112,000	$0.7904	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 11, 2025, subject to Reporting Person's continued service relationship with the Issuer on such vesting date.